title: Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
abstract: Spinal muscular atrophy (SMA), characterized by specific degeneration of spinal motor neurons, is caused by mutations in the survival of motor neuron 1, telomeric (SMN1) gene and subsequent decreased levels of functional SMN. How the deficiency of SMN, a ubiquitously expressed protein, leads to spinal motor neuron-specific degeneration in individuals affected by SMA remains unknown. In this study, we examined the role of SMN in mitochondrial axonal transport and morphology in human motor neurons by generating SMA type 1 patient-specific induced pluripotent stem cells (iPSCs) and differentiating these cells into spinal motor neurons. The initial specification of spinal motor neurons was not affected, but these SMA spinal motor neurons specifically degenerated following long-term culture. Moreover, at an early stage in SMA spinal motor neurons, but not in SMA forebrain neurons, the number of mitochondria, mitochondrial area and mitochondrial transport were significantly reduced in axons. Knocking down of SMN expression led to similar mitochondrial defects in spinal motor neurons derived from human embryonic stem cells, confirming that SMN deficiency results in impaired mitochondrial dynamics. Finally, the application of N-acetylcysteine (NAC) mitigated the impairment in mitochondrial transport and morphology and rescued motor neuron degeneration in SMA long-term cultures. Furthermore, NAC ameliorated the reduction in mitochondrial membrane potential in SMA spinal motor neurons, suggesting that NAC might rescue apoptosis and motor neuron degeneration by improving mitochondrial health. Overall, our data demonstrate that SMN deficiency results in abnormal mitochondrial transport and morphology and a subsequent reduction in mitochondrial health, which are implicated in the specific degeneration of spinal motor neurons in SMA.
authors.affiliation: Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030, USA.
authors.forename: Chong-Chong
authors.initials: CC
authors.lastname: Xu
authors.affiliation: Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030, USA.
authors.forename: Kyle R
authors.initials: KR
authors.lastname: Denton
authors.affiliation: Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030, USA.
authors.forename: Zhi-Bo
authors.initials: ZB
authors.lastname: Wang
authors.affiliation: Department of Regenerative Medicine, Tongji University School of Medicine, Shanghai 200092, China.
authors.forename: Xiaoqing
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Department of Neuroscience, University of Connecticut Health Center, Farmington, CT 06030, USA Stem Cell Institute, University of Connecticut, Farmington, CT 06030, USA xjli@uchc.edu.
authors.forename: Xue-Jun
authors.initials: XJ
authors.lastname: Li
mesh_terms: D000111:Acetylcysteine / Q000737:chemistry; D000818:Animals; D001692:Biological Transport; D053148:Caspase 3 / Q000378:metabolism; D053179:Caspase 7 / Q000378:metabolism; D002454:Cell Differentiation; D002478:Cells, Cultured; D004195:Disease Models, Animal; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology; D007621:Karyotyping; D008564:Membrane Potentials; D051379:Mice; D016513:Mice, SCID; D008928:Mitochondria / Q000473:pathology*; D009046:Motor Neurons / Q000473:pathology*; D009134:Muscular Atrophy, Spinal / Q000473:pathology*; D016133:Polymerase Chain Reaction; D016548:Prosencephalon / Q000503:physiopathology
chemical_list: D053148:Caspase 3; D053179:Caspase 7; D000111:Acetylcysteine
keywords: Human embryonic stem cells; Induced pluripotent stem cells; Mitochondrial transport and morphology; Spinal muscular atrophy; hESCs; iPSCs